Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice

Author:

Chappell Alfred E1ORCID,Gaus Hans J1,Berdeja Andres1,Gupta Ruchi1,Jo Minji1,Prakash Thazha P1,Oestergaard Michael1,Swayze Eric E1,Seth Punit P1ORCID

Affiliation:

1. Ionis Pharmaceuticals, Inc. 2855 Gazelle Court, Carlsbad, CA 92010, USA

Abstract

AbstractConjugation of antisense oligonucleotide (ASO) with a variety of distinct lipophilic moieties like fatty acids and cholesterol increases ASO accumulation and activity in multiple tissues. While lipid conjugation increases tissue exposure in mice and reduces excretion of ASO in urine, histological review of skeletal and cardiac muscle indicates that the increased tissue accumulation of lipid conjugated ASO is isolated to the interstitium. Administration of palmitic acid-conjugated ASO (Palm-ASO) in mice results in a rapid and substantial accumulation in the interstitium of muscle tissue followed by relatively rapid clearance and only slight increases in intracellular accumulation in myocytes. We propose a model whereby increased affinity for lipid particles, albumin, and other plasma proteins by lipid-conjugation facilitates ASO transport across endothelial barriers into tissue interstitium. However, this increased affinity for lipid particles and plasma proteins also facilitates the transport of ASO from the interstitium to the lymph and back into circulation. The cumulative effect is only a slight (∼2-fold) increase in tissue accumulation and similar increase in ASO activity. To support this proposal, we demonstrate that the activity of lipid conjugated ASO was reduced in two mouse models with defects in endothelial transport of macromolecules: caveolin-1 knockout (Cav1−/−) and FcRn knockout (FcRn−/−).

Funder

Ionis Pharmaceuticals, Inc.

Publisher

Oxford University Press (OUP)

Subject

Genetics

Reference39 articles.

1. RNA-targeted therapeutics;Crooke;Cell Metab.,2018

2. Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides;Geary;Curr. Opin. Investig. Drugs,2001

3. Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides;Geary;Adv. Drug. Deliv. Rev.,2015

4. Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1;Pandey;J. Pharmacol. Exp. Ther.,2015

5. Targeting DMPK with antisense oligonucleotide improves muscle strength in myotonic dystrophy type 1 mice;Jauvin;Mol. Ther. Nucleic Acids,2017

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3